Incidence of skeletal morbidity rates over time in patients with multiple myeloma-related bone disease as reported in randomized trials employing bone-modifying agents

Author： Poon Michael   Zeng Liang   Zhang Liying   Hsiao Janey   Wong Erin   Lam Henry   Bedard Gillian   Chow Edward  

Publisher： Future Medicine

ISSN： 2042-6305

Source： Journal of Comparative Effectiveness Research, Vol.2, Iss.1, 2013-01, pp. : 69-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effects of bortezomib on bone disease in patients with multiple myeloma

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 618-623

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Impact of Mast Cell Density on the Progression of Bone Disease in Multiple Myeloma Patients

By  

International Archives of Allergy and Immunology, Vol. 168, Iss. 4, 2016-02 ,pp. : 263-268

Karger

Access to resources Recommend Favorite

A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 1998-02 ,pp. : 317-325

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 1, 2015-01 ,pp. : 60-66

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low Incidence of Human Herpesvirus 8 in Bone Marrow Samples from Brazilian Patients with Multiple Myeloma

By  

Acta Haematologica, Vol. 105, Iss. 4, 2001-08 ,pp. : 247-248

Karger

Access to resources Recommend Favorite